News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lonza Inc., Hyglos Reach on Global Settlement Agreement for Endotoxin Detection Patents


3/20/2013 9:27:49 AM

Basel-headquartered Lonza Walkersville, Inc. and Hyglos GmbH, an internationally active German biotech company, announced that they have reached a mutually beneficial global settlement which includes a licence agreement for Hyglos under certain Lonza patents in the area of endotoxin detection. Specifically, the agreement allows Hyglos to use recombinant factor C technology protected by Lonza’s patents to produce Hyglos’ own endotoxin products. The agreement also includes the dismissal of the law suit Lonza previously filed against Hyglos. The terms of the settlement are confidential.

Read at PharmaBiz

comments powered by Disqus
PharmaBiz
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES